Millipore Sigma Vibrant Logo

586005 Thapsigargin - CAS 67526-95-8 - Calbiochem

Thapsigargin, CAS 67526-95-8, is a cell-permeable, tumor-promoting sesquiterpene lactone that releases calcium by non-competitvley inhibiting endoplasmic reticular Ca2+-ATPase (IC₅₀ = 4-13 nM).

Thapsigargin - CAS 67526-95-8 - Calbiochem: のSDS（安全データシート）、CoA（試験成績書）およびCoQ（品質証明書）、カタログなど製品関連の技術資料を入手いただけます。
Primary Target: endoplasmic reticular Ca2+ ATPase
View This Product on Sigma-Aldrich
586005
価格＆在庫状況を照会

概要

Replacement Information

主要スペック表

CAS #Empirical Formula
67526-95-8C₃₄H₅₀O₁₂

価格＆在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
586005-1MGCN
在庫状況検索中…
—
現在国内在庫なし 現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      		 樹脂ｱﾝﾌﾟﾙ 1 mg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示　
      値引
      ()
       
      —
      弊社照会
      		 —
      Description
      OverviewA cell-permeable tumor-promoting sesquiterpene lactone that releases Ca2+ by inhibiting endoplasmic reticular Ca2+-ATPase (IC50 = 4-13 nM). Does not increase inositol phosphates and has no significant effect on protein kinase C. Increases Ca2+-dependent Na+ influx in human platelets in a dose-dependent manner. Induces apoptosis in rat thymocytes and in human hepatoma cells. Shown to induce apoptosis in alveolar rhabdomyosarcoma cells by elevating Akt-stimulated PAX3-FOXO1 phosphorylation and promoting its proteasomal degradation.
      Catalogue Number586005
      Brand Family Calbiochem®
      References
      ReferencesJothi, M., et al. 2013. Mol. Cancer Ther. In press.
      Won, J.G. and Orth, D.N. 1995. Endocrinology 136, 5399.
      Tepel, M., et al. 1994. Biochim. Biophys. Acta 1220, 248.
      Begum, N., et al. 1993. J. Biol. Chem. 268, 3352.
      Low, A.M., et al. 1993. Eur. J. Pharmacol. 230, 53.
      Tsukamoto, A. and Karneko, Y. 1993. Cell. Biol. Int. 17, 969.
      Wong, W.L., et al. 1993. Biochem. J. 289, 71.
      Glennon, M.C., et al. 1992. J. Biol. Chem. 267, 25568.
      Xu, Y., et al. 1992. J. Neurochem. 59, 2224.
      Mason, M.J., et al. 1991. J. Biol. Chem. 266, 20856.
      Thastrup, O., et al. 1990. Proc. Natl. Acad. Sci. USA 87, 2466.
      Product Information
      CAS number67526-95-8
      ATP CompetitiveN
      FormColorless solid
      Hill FormulaC₃₄H₅₀O₁₂
      Chemical formulaC₃₄H₅₀O₁₂
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ200
      Applications
      Biological Information
      Primary Targetendoplasmic reticular Ca2+ ATPase
      Primary Target IC<sub>50</sub>4-13 nM against endoplasmic reticular Ca2+-ATPase
      Purity≥97% by TLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 36/37/38-42

      Irritating to eyes, respiratory system and skin.
      May cause sensitization by inhalation.
      S PhraseS: 36/37/39-26

      Wear suitable protective clothing, gloves and eye/face protection.
      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Irritant
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for 2-3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      586005-1MGCN 04055977265026

      Documentation

      Thapsigargin - CAS 67526-95-8 - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート（(M)SDS） 

      Thapsigargin - CAS 67526-95-8 - Calbiochem 試験成績書（CoA）

      タイトルロット番号
      586005

      参考資料

      参考資料の概要
      Jothi, M., et al. 2013. Mol. Cancer Ther. In press.
      Won, J.G. and Orth, D.N. 1995. Endocrinology 136, 5399.
      Tepel, M., et al. 1994. Biochim. Biophys. Acta 1220, 248.
      Begum, N., et al. 1993. J. Biol. Chem. 268, 3352.
      Low, A.M., et al. 1993. Eur. J. Pharmacol. 230, 53.
      Tsukamoto, A. and Karneko, Y. 1993. Cell. Biol. Int. 17, 969.
      Wong, W.L., et al. 1993. Biochem. J. 289, 71.
      Glennon, M.C., et al. 1992. J. Biol. Chem. 267, 25568.
      Xu, Y., et al. 1992. J. Neurochem. 59, 2224.
      Mason, M.J., et al. 1991. J. Biol. Chem. 266, 20856.
      Thastrup, O., et al. 1990. Proc. Natl. Acad. Sci. USA 87, 2466.

      カタログ

      タイトル
      Caspases and other Apoptosis Related Tools Brochure
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision11-October-2013 JSW
      DescriptionA cell-permeable tumor-promoting sesquiterpene lactone that releases Ca2+ by inhibiting endoplasmic reticular Ca2+-ATPase. Does not increase inositol phosphates and has no significant effect on protein kinase C. Increases Ca2+-dependent Na+ influx in human platelets in a dose-dependent manner. Activates apoptosis in rat thymocytes and induces apoptosis in human hepatoma cells. Shown to induce apoptosis in alveolar rhabdomyosarcoma cells by elevating Akt-stimulated PAX3-FOXO1 phosphorylation and promoting its proteasomal degradation.
      FormColorless solid
      CAS number67526-95-8
      Chemical formulaC₃₄H₅₀O₁₂
      Structure formulaStructure formula
      Purity≥97% by TLC
      SolubilityDMSO (>1 mg/ml) or ethanol (5 mg/ml)
      Storage Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for 2-3 months at -20°C.
      Toxicity Irritant
      ReferencesJothi, M., et al. 2013. Mol. Cancer Ther. In press.
      Won, J.G. and Orth, D.N. 1995. Endocrinology 136, 5399.
      Tepel, M., et al. 1994. Biochim. Biophys. Acta 1220, 248.
      Begum, N., et al. 1993. J. Biol. Chem. 268, 3352.
      Low, A.M., et al. 1993. Eur. J. Pharmacol. 230, 53.
      Tsukamoto, A. and Karneko, Y. 1993. Cell. Biol. Int. 17, 969.
      Wong, W.L., et al. 1993. Biochem. J. 289, 71.
      Glennon, M.C., et al. 1992. J. Biol. Chem. 267, 25568.
      Xu, Y., et al. 1992. J. Neurochem. 59, 2224.
      Mason, M.J., et al. 1991. J. Biol. Chem. 266, 20856.
      Thastrup, O., et al. 1990. Proc. Natl. Acad. Sci. USA 87, 2466.